| Serial Number | 90181491 |
| Word Mark | VALO OPAL COMPUTATIONAL PLATFORM |
| Filing Date | Tuesday, September 15, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, July 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | downloadable and recorded software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement |
| NOT AVAILABLE | "COMPUTATIONAL PLATFORM" |
| Goods and Services | Research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; software as a service for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 27, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 27, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Valo Health, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lexington, MA 02421 |
| Event Date | Event Description |
| Wednesday, October 21, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 27, 2021 | ASSIGNED TO EXAMINER |
| Thursday, February 11, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, February 11, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, February 11, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 25, 2021 | SUSPENSION LETTER WRITTEN |
| Wednesday, August 25, 2021 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, August 25, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, April 29, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, May 25, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, May 25, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, May 25, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, December 5, 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, November 8, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, January 4, 2023 | FINAL REFUSAL WRITTEN |
| Wednesday, January 4, 2023 | FINAL REFUSAL E-MAILED |
| Wednesday, January 4, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, March 24, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, February 22, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 23, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 22, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, March 24, 2023 | SUSPENSION LETTER WRITTEN |
| Friday, March 24, 2023 | LETTER OF SUSPENSION E-MAILED |
| Thursday, December 14, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Saturday, January 6, 2024 | SUBSEQUENT FINAL EMAILED |
| Saturday, January 6, 2024 | SUBSEQUENT FINAL REFUSAL WRITTEN |
| Saturday, January 6, 2024 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
| Monday, July 29, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, July 29, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, March 28, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, March 28, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, June 12, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, June 12, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, June 12, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |